Seres Therapeutics, Inc. (MCRB) › Net IncomeSeres Therapeutics, Inc. (MCRB) — Net IncomeAnnual figures by fiscal year, from SEC filings.2013: -$6.10M2014: -$16.71M2015: -$54.78M2016: -$91.58M2017: -$89.38M2018: -$98.94M2019: -$70.28M2020: -$89.13M2021: -$65.58M2022: -$250.16M2023: -$113.72M2024: $136.0K2025: $5.70M$5.70M2013Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025$5.70M+4088.2%2024$136.0K+100.1%2023-$113.72M+54.5%2022-$250.16M-281.5%2021-$65.58M+26.4%2020-$89.13M-26.8%2019-$70.28M+29.0%2018-$98.94M-10.7%2017-$89.38M+2.4%2016-$91.58M-67.2%2015-$54.78M-227.8%2014-$16.71M-173.8%2013-$6.10M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share